Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

12.31
Delayed Data
As of 4:00pm ET
 -0.62 / -4.80%
Today’s Change
10.52
Today|||52-Week Range
19.98
+0.33%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close12.93
Today’s open12.82
Day’s range12.15 - 12.82
Volume1,251,199
Average volume (3 months)1,665,648
Market cap$2.0B
Dividend yield--
Data as of 4:00pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-78.92%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book272.10

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-2.65-5.83%
EXASExact Sciences Corp-0.47-2.47%
JUNOJuno Therapeutics In...-0.92-4.60%
ONCESpark Therapeutics I...-2.93-5.13%
Data as of 4:00pm ET, 01/17/2017

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts


Search for Jobs